These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4070392)

  • 21. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
    Foss JF
    Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naltrexone and nalmefene attenuate cocaine place preference in male mice.
    Windisch KA; Reed B; Kreek MJ
    Neuropharmacology; 2018 Sep; 140():174-183. PubMed ID: 30048644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of the antagonistic effects of 6 beta-naltrexol and naltrexone against morphine analgesia].
    Yan LD; Gong ZH; Yao XJ; Qin BY
    Yao Xue Xue Bao; 2003 Aug; 38(8):578-81. PubMed ID: 14628446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for a peripheral action of thyrotropin releasing hormone on gastrointestinal transit in mice.
    Bansinath M; Bhargava HN
    Neuropharmacology; 1988 Apr; 27(4):433-7. PubMed ID: 2901674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretion.
    Blank MS; Mann DR; Daugherty DT; Sridiran R; Murphy JR
    Life Sci; 1986 Oct; 39(17):1493-99. PubMed ID: 3020332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of methylnaltrexone versus naloxone for reversal of morphine-induced depression of hypoxic ventilatory response.
    Amin HM; Sopchak AM; Foss JF; Esposito BF; Roizen MF; Camporesi EM
    Anesth Analg; 1994 Apr; 78(4):701-5. PubMed ID: 8135389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. M5 muscarinic receptor knockout mice show reduced morphine-induced locomotion but increased locomotion after cholinergic antagonism in the ventral tegmental area.
    Steidl S; Yeomans JS
    J Pharmacol Exp Ther; 2009 Jan; 328(1):263-75. PubMed ID: 18849356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the sites of opioid influence on anterior pituitary hormone secretion using a quaternary opiate antagonist.
    Simpkins JW; Swager D; Millard WJ
    Neuroendocrinology; 1991 Oct; 54(4):384-90. PubMed ID: 1661859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histamine H2 receptors mediate morphine-induced locomotor hyperactivity of the C57BL/6J mouse.
    Mickley GA
    Behav Neurosci; 1986 Feb; 100(1):79-84. PubMed ID: 3954883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylnaltrexone prevents morphine-induced kaolin intake in the rat.
    Aung HH; Mehendale SR; Xie JT; Moss J; Yuan CS
    Life Sci; 2004 Apr; 74(22):2685-91. PubMed ID: 15043984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential Delivery of an Opioid Antagonist to the Fetal Brain in Pregnant Mice.
    Oberdick J; Ling Y; Phelps MA; Yudovich MS; Schilling K; Sadee W
    J Pharmacol Exp Ther; 2016 Jul; 358(1):22-30. PubMed ID: 27189967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice.
    Stevenson GW; Bilsky EJ; Negus SS
    J Pain; 2006 Jun; 7(6):408-16. PubMed ID: 16750797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology.
    Zádor F; Király K; Váradi A; Balogh M; Fehér Á; Kocsis D; Erdei AI; Lackó E; Zádori ZS; Hosztafi S; Noszál B; Riba P; Benyhe S; Fürst S; Al-Khrasani M
    Eur J Pharmacol; 2017 Aug; 809():111-121. PubMed ID: 28502630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of peripheral and central opioid activity in analgesia induced by restraint stress.
    Kelly SJ; Franklin KB
    Life Sci; 1987 Aug; 41(6):789-94. PubMed ID: 3039272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphine preexposure attenuates the aversive properties of opiates without preexposure to the aversive properties.
    Martin GM; Bechara A; van der Kooy D
    Pharmacol Biochem Behav; 1988 Jul; 30(3):687-92. PubMed ID: 3211978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of in vivo morphine treatment on antibody responses in C57BL/6 bgJ/bgJ (beige) mice.
    Bussiere JL; Adler MW; Rogers TJ; Eisenstein TK
    Life Sci; 1993; 52(4):PL43-8. PubMed ID: 8421432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic dissociation of multiple morphine effects among C57BL/6J, DBA/2J and C3H/HeJ inbred mouse strains.
    Belknap JK; Noordewier B; Lamé M
    Physiol Behav; 1989 Jul; 46(1):69-74. PubMed ID: 2813556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quaternary naltrexone reveals the central mediation of conditional opioid analgesia.
    Calcagnetti DJ; Helmstetter FJ; Fanselow MS
    Pharmacol Biochem Behav; 1987 Jul; 27(3):529-31. PubMed ID: 2821555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine-induced Straub tail reaction in mice treated with serotonergic compounds.
    Belozertseva IV; Dravolina OA; Tur MA; Semina MG; Zvartau EE; Bespalov AY
    Eur J Pharmacol; 2016 Nov; 791():1-7. PubMed ID: 27565217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine exacerbates anaphylactic shock in mice by stimulating central opiate receptors.
    Amir S
    Neurosci Lett; 1983 Sep; 40(2):169-74. PubMed ID: 6314208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.